Admission to trading of Biofrontera’s 1.00% qualified subordinated mandatory convertible bond 2020/2021
August 20, 2020 13:00 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) -- On August 18, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE 00 6046113) announced the successful placement of the 1.00% qualified...
Biofrontera announces conference call to be held on August 27, 2020 to discuss half-year 2020 financial results
August 19, 2020 04:30 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Capital measure oversubscribed: Placement of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021
August 18, 2020 05:00 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 18, 2020 (GLOBE NEWSWIRE) -- In a press release dated July 27, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE0006046113) announced the issuance of up to 2,638,150...
Result of the subscription of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021
August 13, 2020 16:50 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (shares of Biofrontera AG ISIN: DE0006046113) announced on July 27, 2020 the issuance of the 1.00% qualified subordinated...
Biofrontera AG announces subscription price for 1.00 % qualified subordinated mandatory convertible bond 2020/2021
August 10, 2020 10:00 ET
|
Biofrontera AG
Leverkusen, Aug. 10, 2020 (GLOBE NEWSWIRE) -- The Executive Board of Biofrontera AG (shares of Biofrontera AG ISIN: DE0006046113) has decided on 27 July 2020, with the approval of the Supervisory...
Biofrontera AG resolves to issue qualified subordinated mandatory convertible bonds
July 27, 2020 13:15 ET
|
Biofrontera AG
Leverkusen, Germany, July 27, 2020 (GLOBE NEWSWIRE) -- The Management Board of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today resolved, with the approval of the Supervisory...
Supervisory Board of Biofrontera AG renews Management Board appointment
July 23, 2020 08:30 ET
|
Biofrontera AG
Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today...
Biofrontera reports preliminary unaudited sales revenue for the first six months of 2020
July 14, 2020 06:08 ET
|
Biofrontera AG
Leverkusen, Germany, July 14, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
Biofrontera confirms financing need
June 30, 2020 08:30 ET
|
Biofrontera AG
Leverkusen, Germany, June 30, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today confirmed the...
Results of the 2020 Annual General Meeting of Biofrontera AG
May 28, 2020 11:36 ET
|
Biofrontera AG
Leverkusen, Germany, May 28, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, an international...